Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
Sponsor: RTI International
Summary
The goal of this clinical trial is to compare the effectiveness of a multi-faceted implementation strategy, the Systems Analysis and Improvement Approach for Naloxone (SAIA-N), in syringe service programs (SSPs). The main questions it aims to answer are: * Does SAIA-N improve naloxone distribution (number of doses, number of people receiving naloxone) compared to implementation as usual (IAU)? * What are the costs associated with SAIA-N and how cost-effective is the strategy? SSPs randomized to the SAIA-N arm will participate in the strategy for a period of 12-months during which they will meet 1-2 times each month with a SAIA coach who will assist the SSP in optimizing their naloxone distribution. Researchers will compare SAIA-N to IAU to see if naloxone distribution and costs and cost-effectiveness differ by group.
Official title: Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2023-07-01
Completion Date
2026-06-30
Last Updated
2025-05-18
Healthy Volunteers
Yes
Conditions
Interventions
Naloxone
Naloxone
Usual intervention
usual administered drug for overdose
Locations (1)
RTI International
Berkeley, California, United States